Groningen, Netherlands

Deepak Halenahally Veeregowda

This inventor holds 1 USPTO granted patent. Top assignees: Academisch Ziekenhuis Groningen, Rijksunviersiteit Groningen. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Deepak Halenahally Veeregowda. Retrieved from https://idiyas.com/inventor/deepak-halenahally-veeregowda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Deepak Halenahally Veeregowda: Innovator in Biolubricant Technology

Introduction

Deepak Halenahally Veeregowda is a notable inventor based in Groningen, Netherlands. He has made significant contributions to the field of medicine, particularly in the development of biolubricants. His innovative work focuses on recombinant cationic polypeptides and their therapeutic applications.

Latest Patents

Deepak holds a patent for "Biolubricant polypeptides and therapeutic uses thereof." This invention relates to a biolubricant substance that comprises the amino acid sequence [(GKGVP)9], where n is ≥5. This advancement has the potential to enhance medical applications by providing effective lubrication in various therapeutic contexts.

Career Highlights

Throughout his career, Deepak has worked with esteemed institutions such as Rijksuniversiteit Groningen and Academisch Ziekenhuis Groningen. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Deepak has collaborated with notable colleagues, including Prashant Kumar Sharma and Andreas Herrmann. These partnerships have further enriched his research and innovation efforts.

Conclusion

Deepak Halenahally Veeregowda is a pioneering inventor whose work in biolubricant technology is making a significant impact in the medical field. His contributions are paving the way for new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…